Filing Details
- Accession Number:
- 0001209191-17-013103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 14:48:59
- Reporting Period:
- 2017-02-15
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 14:48:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1625101 | Pulse Biosciences Inc. | PLSE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1507650 | Maky Zanganeh | 849 Mitten Road, Suite 104 Burlingame CA 90401 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-15 | 13,000 | $11.97 | 33,474 | No | 4 | P | Indirect | Dependent Minor |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Dependent Minor |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 258,935 | Direct |
Footnotes
- This is the weighted average purchase price of the shares, which ranged from $11.95 to $12.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.